Position in LLY
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$2,136,556,831
+$649,928,902 QoQ
Shares Held
1,781,310
+10.2% QoQ
Ownership
0.189%
of shares outstanding
% of Portfolio
1.90%
of 13F equity value
Holder Rank
#48
of 4,605 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Swedbank AB holds $5,796,975,204 across 10 Drug Manufacturers - General names. LLY ranks #1 (36.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,781,310 | $2,136,556,831 | |
| 2 | JNJ |
Johnson & Johnson
|
3,624,513 | $920,517,565 | |
| 3 | MRK |
Merck & Co., Inc.
|
6,360,649 | $817,343,396 | |
| 4 | ABBV |
AbbVie Inc.
|
2,634,628 | $662,977,789 | |
| 5 | AZN |
Astrazeneca PLC
|
2,241,677 | $425,066,792 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,903,177 | $240,447,381 | |
| 7 | AMGN |
Amgen Inc
|
517,466 | $187,384,787 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,043,205 | $175,349,471 |
All Filings in LLY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,136,556,831 | 1,781,310 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $1,486,627,929 | 1,616,304 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $1,793,588,426 | 1,668,951 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,185,139,669 | 1,553,263 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $1,030,483,312 | 1,321,929 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $879,257,048 | 1,138,934 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $983,843,457 | 1,110,508 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $1,084,010,568 | 1,197,299 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $932,796,600 | 1,199,029 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $671,685,891 | 1,152,278 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $579,268,922 | 1,078,452 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $494,538,002 | 1,054,497 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $367,823,767 | 1,071,061 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $363,872,878 | 994,623 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $285,442,708 | 882,767 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $227,216,492 | 700,788 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $196,132,234 | 684,891 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $187,156,727 | 677,564 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $162,184,160 | 701,944 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $168,890,914 | 735,844 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $137,461,595 | 735,797 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||